James E Mitchell1, Kristine Steffen2, Scott Engel2, Wendy C King3, Jia-Yuh Chen3, Ken Winters4, Stephanie Sogg5, Cindy Sondag2, Melissa Kalarchian6, Katherine Elder7. 1. Neuropsychiatric Research Institute and the University of North Dakota School of Medicine, Fargo, North Dakota. Electronic address: jmitchell@nrifargo.com. 2. Neuropsychiatric Research Institute and the University of North Dakota School of Medicine, Fargo, North Dakota. 3. Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania. 4. University of Minnesota Medical School, Minneapolis, Minnesota. 5. Massachusetts General Hospital Weight Center, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts. 6. Duquesne University, Pittsburgh, Pennsylvania. 7. Pacific University, Hillsboro, Oregon.
Abstract
BACKGROUND: Recent literature suggests that some patients may develop addictive disorders after bariatric surgery, in particular after Roux-en-Y gastric bypass (RYGB). These may include traditional addictions and so called "behavioral addictions," although prevalence data on the latter have not been published. The objective of this study was to establish the prevalence of addictive behaviors in adults after RYGB. METHODS: Participants from a large observational study of bariatric surgery who had undergone RYGB were recruited to complete additional measures. Of 241 consented participants, 201 provided data (i.e., Structured Clinical Interview for DSM-IV Axis I [SCID], additional Impulsive Control Disorder Modules, and various self-report measures, including the Alcohol Use Disorder Identification Test [AUDIT]) to assess status before surgery and in the first 3 postoperative years. RESULTS: Based on the SCID, 16 (8.0%) developed alcohol use disorder [AUD] within 3 years post-RYGB, 7 (43.8%) of whom had no history of AUD. When both the SCID and AUDIT were used to identify AUD, the corresponding numbers/percentages were 32 (18.4%) and 13 (40.6%). Data on other behavioral addictive disorders indicated 19 (9.5%) had a postsurgery disorder, 6 (31.6%) of whom had no history. CONCLUSION: These data add to a growing literature suggesting there is a substantial risk for the development of AUD after bariatric surgery. Understanding the risk for nondrug-related addictive disorders requires more data from larger studies before clear conclusions can be drawn.
BACKGROUND: Recent literature suggests that some patients may develop addictive disorders after bariatric surgery, in particular after Roux-en-Y gastric bypass (RYGB). These may include traditional addictions and so called "behavioral addictions," although prevalence data on the latter have not been published. The objective of this study was to establish the prevalence of addictive behaviors in adults after RYGB. METHODS:Participants from a large observational study of bariatric surgery who had undergone RYGB were recruited to complete additional measures. Of 241 consented participants, 201 provided data (i.e., Structured Clinical Interview for DSM-IV Axis I [SCID], additional Impulsive Control Disorder Modules, and various self-report measures, including the Alcohol Use Disorder Identification Test [AUDIT]) to assess status before surgery and in the first 3 postoperative years. RESULTS: Based on the SCID, 16 (8.0%) developed alcohol use disorder [AUD] within 3 years post-RYGB, 7 (43.8%) of whom had no history of AUD. When both the SCID and AUDIT were used to identify AUD, the corresponding numbers/percentages were 32 (18.4%) and 13 (40.6%). Data on other behavioral addictive disorders indicated 19 (9.5%) had a postsurgery disorder, 6 (31.6%) of whom had no history. CONCLUSION: These data add to a growing literature suggesting there is a substantial risk for the development of AUD after bariatric surgery. Understanding the risk for nondrug-related addictive disorders requires more data from larger studies before clear conclusions can be drawn.
Authors: Krisztina Berczik; Attila Szabó; Mark D Griffiths; Tamás Kurimay; Bernadette Kun; Róbert Urbán; Zsolt Demetrovics Journal: Subst Use Misuse Date: 2012-01-04 Impact factor: 2.164
Authors: Wendy C King; Jia-Yuh Chen; James E Mitchell; Melissa A Kalarchian; Kristine J Steffen; Scott G Engel; Anita P Courcoulas; Walter J Pories; Susan Z Yanovski Journal: JAMA Date: 2012-06-20 Impact factor: 56.272
Authors: Kristine J Steffen; Scott G Engel; Garrett A Pollert; Cao Li; James E Mitchell Journal: Surg Obes Relat Dis Date: 2013-02-09 Impact factor: 4.734
Authors: Paula J D Wolvers; Sjoerd C Bruin; Willem M Mairuhu; Monique de Leeuw-Terwijn; Barbara A Hutten; Dees P M Brandjes; Victor E A Gerdes Journal: Obes Surg Date: 2020-01 Impact factor: 4.129
Authors: Lisa R Miller-Matero; Joseph P Coleman; Leah LaLonde; Kellie M Martens; Aaron Hamann; Arthur M Carlin Journal: Obes Surg Date: 2019-08 Impact factor: 4.129
Authors: Janey S A Pratt; Allen Browne; Nancy T Browne; Matias Bruzoni; Megan Cohen; Ashish Desai; Thomas Inge; Bradley C Linden; Samer G Mattar; Marc Michalsky; David Podkameni; Kirk W Reichard; Fatima Cody Stanford; Meg H Zeller; Jeffrey Zitsman Journal: Surg Obes Relat Dis Date: 2018-03-23 Impact factor: 4.734
Authors: Meg H Zeller; Gia A Washington; James E Mitchell; David B Sarwer; Jennifer Reiter-Purtill; Todd M Jenkins; Anita P Courcoulas; James L Peugh; Marc P Michalsky; Thomas H Inge Journal: Surg Obes Relat Dis Date: 2016-05-25 Impact factor: 4.734
Authors: Kathryn E Smith; Scott G Engel; Kristine J Steffen; Luis Garcia; Karen Grothe; Afton Koball; James E Mitchell Journal: Obes Surg Date: 2018-05 Impact factor: 4.129